Indo US Bio-Tech IPO vs Narmada Agrobase IPO

Comparison between Indo US Bio-Tech IPO and Narmada Agrobase IPO.

IPO Details

Indo US Bio-Tech IPO is a SME Fixed Price IPO proposed to list at BSE SME while Narmada Agrobase IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Indo US Bio-Tech IPO is up to ₹6.92 Cr whereas the issue size of the Narmada Agrobase IPO is up to ₹7.09 Cr. The final issue price of Indo US Bio-Tech IPO is ₹51.00 per share and of Narmada Agrobase IPO is ₹32.00 per share.

 Indo US Bio-Tech IPONarmada Agrobase IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹51.00 per share₹32.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size2000 shares4000 shares
Fresh Issue Size13,56,000 shares22,16,000 shares
Fresh Issue Size (Amount)up to ₹6.92 Crup to ₹7.09 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total13,56,000 shares22,16,000 shares
Issue Size Total (Amount)up to ₹6.92 Crup to ₹7.09 Cr

IPO Timetable

Indo US Bio-Tech IPO opens on Apr 30, 2018, while Narmada Agrobase IPO opens on Mar 28, 2018. The closing date of Indo US Bio-Tech IPO and Narmada Agrobase IPO is May 03, 2018, and Apr 11, 2018, respectively.

 Indo US Bio-Tech IPONarmada Agrobase IPO
Issue OpenApr 30, 2018Mar 28, 2018
Issue CloseMay 03, 2018Apr 11, 2018
Basis Of Allotment (Tentative)May 08, 2018Apr 16, 2018
Listing date (Tentative)May 11, 2018Apr 19, 2018

Financials & KPIs

Indo US Bio-Tech IPO P/E ratio is , as compared to Narmada Agrobase IPO P/E ratio of .

 Indo US Bio-Tech IPONarmada Agrobase IPO
Financials

Company Financials (Restated)

Period Ended31 Oct 201731 Mar 201731 Mar 201631 Mar 2015
Assets20.5612.9413.697.68
Total Income15.8924.5819.1519.66
Profit After Tax0.740.650.360.50
NET Worth4.633.893.252.90
Reserves and Surplus3.142.401.771.41
Total Borrowing6.394.864.671.67
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended30 Sep 201731 Mar 201731 Mar 201631 Mar 2015
Assets13.9113.6710.738.96
Total Income17.4034.4530.7122.04
Profit After Tax0.210.300.190.14
NET Worth5.142.432.121.35
Reserves and Surplus2.540.610.300.11
Total Borrowing6.919.457.246.57
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%100%
Promoter Shareholding (Post-Issue)70.54%68.92%
Market Cap₹24.76 Cr.₹24.09 Cr.

Shares Offered

In the Indo US Bio-Tech IPO Retail Individual Investors (RII) are offered 6,78,000 shares while in Narmada Agrobase IPO retail investors are offered 6,78,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Indo US Bio-Tech IPO and 0 shares in Narmada Agrobase IPO.

 Indo US Bio-Tech IPONarmada Agrobase IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation74,000 shares1,24,000 shares
QIB0 shares0 shares
NII6,78,000 shares11,08,000 shares
RII6,78,000 shares11,08,000 shares
Employee0 shares0 shares
Total13,56,000 shares22,16,000 shares

Bids Received (Subscription)

Indo US Bio-Tech IPO subscribed 19.69x in total, whereas Narmada Agrobase IPO subscribed 1.21x.

 Indo US Bio-Tech IPONarmada Agrobase IPO
NII (times)19.52x0.93x
RII (times)19.87x1.48x
Total (times)19.69x1.21x

Compare with others

Compare:

Indo US Bio-Tech IPO Vs Narmada Agrobase IPO